Cardlytics Inc (NASDAQ:CDLX) shares are taking a beating after reporting Q3 numbers yesterday afternoon. CDLX reported a non-GAAP loss of $(0.15), which was better than the $(0.20) loss last year. However, revenue rose just 10.1% year/year to $34.6 mln, that was below prior guidance of $36-38 mln. The Q4 revenue […]
